| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/09/2009 | CN101596193A Application of palmatine in medicine for treating yellow fever virus infection |
| 12/09/2009 | CN101596192A Application of palmatine in medicine for treating dengue virus infection |
| 12/09/2009 | CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor |
| 12/09/2009 | CN101596190A Pharmaceutical application of D-cycloserine |
| 12/09/2009 | CN101596189A Medicinal composition containing imidazole-5-carboxylic derivative |
| 12/09/2009 | CN101596188A Medicament for external application for treating acne |
| 12/09/2009 | CN101596187A Anti-cancer combinations |
| 12/09/2009 | CN101596186A Anti-cancer combinations |
| 12/09/2009 | CN101596185A Application of formononetin in preparation of medicine capable of treating hypertension and ischemic angiocardiopathy and cerebrovascular disease |
| 12/09/2009 | CN101596184A Application of rosmarinic acid as peroxynitrite inhibitor |
| 12/09/2009 | CN101596183A Echinacea oral liquid and preparation method thereof |
| 12/09/2009 | CN101596182A Medicine composition containing salvianolic acid A, preparation method and application thereof as well as freeze-dried powder injection and water injection containing composition |
| 12/09/2009 | CN101596181A Medicinal composition containing dimeticone/simethicone |
| 12/09/2009 | CN101596180A Plant amino acid type chelated calcium, iron and zinc composition and preparation method thereof |
| 12/09/2009 | CN101596179A Medicament composition for treating hyperammonemia and preparation method thereof |
| 12/09/2009 | CN101596178A Medicine composition for treating cold |
| 12/09/2009 | CN101596177A Coenzyme Q10 self-emulsifying composition, preparation method and application thereof |
| 12/09/2009 | CN101596176A Medicine composition for cooling and refreshing as well as dispelling itch |
| 12/09/2009 | CN101596173A Capsule capable of stabilizing acebrophylline |
| 12/09/2009 | CN101596172A Oral preparation capable of dosing fertility-controlling drugs by positioning at small intestine and production method thereof |
| 12/09/2009 | CN101596171A Tamsulosin sustained release tablet and preparation method thereof |
| 12/09/2009 | CN101596170A Trospium chloride slow-release tablet |
| 12/09/2009 | CN101596169A Chitosan nanoparticle for encapsulating adenosine triphosphate and preparation method thereof |
| 12/09/2009 | CN101596168A Lumbar anesthesia special local anaesthetic-glucose lyophilized powder injection as well as preparation method and package method thereof |
| 12/09/2009 | CN101596167A New preparation method of Ozagrel sodium powder injection |
| 12/09/2009 | CN101596166A Aspirin enteric-coated pellet |
| 12/09/2009 | CN101596165A Pantoprazole sodium enteric-coated pellet |
| 12/09/2009 | CN101596164A Dirithromycin enteric coatel granule and preparation method thereof |
| 12/09/2009 | CN101596163A Paracetamol, caffeine and aspirin pellet preparation and preparation method thereof |
| 12/09/2009 | CN101596162A Doxycycline hyclate enteric-coated pellet |
| 12/09/2009 | CN101596161A Preparation method of sterile preparation of lipoalprostadil |
| 12/09/2009 | CN101596160A Alpha-asarone mixed micelle injectio and preparation method thereof |
| 12/09/2009 | CN101596159A New taxol injection and preparation method thereof |
| 12/09/2009 | CN101596158A Compound slow release preparation of acetyl aminophenol, pseudoephedrine and dextromethorphan |
| 12/09/2009 | CN101596157A Compound slow release preparation of pseudoephedrine, chlorphenamine and dextromethorphan |
| 12/09/2009 | CN101596156A Compound sustained-release preparation for paracetamol and pseudoephedrine |
| 12/09/2009 | CN101596155A Teniposide solid lipid nanoparticle and preparation method thereof |
| 12/09/2009 | CN101595874A Validamycin amphiphilic polymer network and synthesis method thereof |
| 12/09/2009 | CN100567339C Polymers and copolymers of N-vinylamides and their use in capillary electrophoresis |
| 12/09/2009 | CN100567315C Precursor medicine of acyclic nucleoside phosphonic acid |
| 12/09/2009 | CN100567314C New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives |
| 12/09/2009 | CN100567309C (E)3,5-di-methoxy-diphenylene-4'-0-phosphates (salt) and its preparing method, medicine composition and use |
| 12/09/2009 | CN100567303C Coumarether compound and use of its composition |
| 12/09/2009 | CN100567301C Chlorophyll derivatives, preparation method and application thereof in medical agricultural chemicals |
| 12/09/2009 | CN100567299C New antifungal compound, preparation method and application |
| 12/09/2009 | CN100567296C Triazolopyridazines as inhibitors of protein kinases |
| 12/09/2009 | CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists |
| 12/09/2009 | CN100567291C Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline |
| 12/09/2009 | CN100567289C 2-(hetero)aryl substituted tetrahydroquinoline derivatives |
| 12/09/2009 | CN100567288C 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain |
| 12/09/2009 | CN100567287C Basic salt of thioctic acid and L-carnitine |
| 12/09/2009 | CN100567285C Joglone possessing anti cancer activity and its preparation method |
| 12/09/2009 | CN100567283C Flavane compounds and use thereof |
| 12/09/2009 | CN100567281C Water soluble anti-HIV component of radix lithospermi and its extracts |
| 12/09/2009 | CN100567279C Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 12/09/2009 | CN100567278C Benzoyl guanidine derivative, preparation method and medical use thereof |
| 12/09/2009 | CN100567276C Tri(cyclo) substituted amide compounds |
| 12/09/2009 | CN100567275C 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents |
| 12/09/2009 | CN100567273C Organic compounds |
| 12/09/2009 | CN100567270C Sulfonyl amide derivatives |
| 12/09/2009 | CN100567267C Arylamidine derivative, salt thereof, and antifungal containing these |
| 12/09/2009 | CN100567266C Cannabinoid receptor ligands |
| 12/09/2009 | CN100567253C Novel succinate salt of O-demethyl-venlafaxine |
| 12/09/2009 | CN100567252C Fenfluramine hydrochloride raw material drug and tablet and its preparing method |
| 12/09/2009 | CN100567242C Hsp90 family protein inhibitors |
| 12/09/2009 | CN100566758C Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
| 12/09/2009 | CN100566754C Gelling agent for controlling and releasing 5-HT3 acceptor antagon and method of preparing the same |
| 12/09/2009 | CN100566727C Chinese medicine ointment for treating burns and scalds and its preparation |
| 12/09/2009 | CN100566722C Method and composition for treatment of adenoviral ocular infections |
| 12/09/2009 | CN100566721C Clindamycin palmitate hydrochloride chewing tablet andi its preparing method |
| 12/09/2009 | CN100566720C Chinese medicine active ingredient composition for treating cardiovascular disease and use thereof |
| 12/09/2009 | CN100566719C Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients |
| 12/09/2009 | CN100566718C Hydrochlorothiazide grain and sugar-coat producing technique of compound luobuma tablets |
| 12/09/2009 | CN100566717C Composition for treating hyperlipemia |
| 12/09/2009 | CN100566716C Composition for treating hyperlipemia |
| 12/09/2009 | CN100566715C Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones |
| 12/09/2009 | CN100566714C Compositions of huperzia serrata alkaloids comprising huperzine A and huperzine B and preparation thereof |
| 12/09/2009 | CN100566713C Use of of aminosubstituted hydroxybenzophenones as photostable UV-filter in cosmetic and pharmaceutical preparations |
| 12/09/2009 | CN100566712C Polyamine compounds for treating chemokine receptor mediated diseases |
| 12/09/2009 | CN100566711C Compound for the treatment of cancer and use thereof |
| 12/09/2009 | CN100566710C New use of 6,7-dehydroroyleanone in pharmaceutical |
| 12/09/2009 | CN100566708C Method of producing hepatic targeting drug microcapsule |
| 12/09/2009 | CN100566705C Preparation method for thin coating medicine for treating cold |
| 12/09/2009 | CN100566704C Sodium fusidate freezing-dried powder injection |
| 12/08/2009 | US7629492 Halo active aromatic sulfonamide organic compounds and odor control uses therefor |
| 12/08/2009 | US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide |
| 12/08/2009 | US7629475 kappa opioid receptors agonist; antidepressants for treating mood disorders, such as depressive disorders and manic disorders, psychological disorders |
| 12/08/2009 | US7629473 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| 12/08/2009 | US7629471 Transcriptional factor, process for producing the same and use thereof |
| 12/08/2009 | US7629468 Neuroprotectants, analgesics or anticonvulsants |
| 12/08/2009 | US7629467 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 12/08/2009 | US7629463 Pesticides that are more effective, less costly, less toxic, environmentally safer; 1-(2-chloromethyl-N-[2-methyl-6-(1-methyl-1H-imidazol-2-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide |
| 12/08/2009 | US7629462 Such as (5-Aminomethyl-2-methylsulfanyl-6-phenyl-pyrimidin-4-yl)-phenylamine; p38 map kinase inhibitors |
| 12/08/2009 | US7629460 Dihydropteridione derivatives, process for their manufacture and their use as medicament |
| 12/08/2009 | US7629458 Preparation of levofloxacin and hemihydrate thereof |
| 12/08/2009 | US7629456 Modified L-nucleic acid |
| 12/08/2009 | US7629387 eremophilane sesquiterpene's such as 13-hydroxy-valencene or nootkatone-1,10-11,12-diepoxide, used to controlling arthropods, such as insects and acarina |
| 12/08/2009 | US7629386 Microbiocides; for disinfecting and/or preserving medical devices, contact lenses |
| 12/08/2009 | US7629385 capable of interfering with pathological processes, taking place in lipid rafts of diseased cells: abnormal raft clustering upon viral infections, formation of oligomeric structures of toxins in lipid rafts; N-(trans-4-tert-butylcyclohexylcarbonyl)-D-erythro-sphingosine |
| 12/08/2009 | US7629384 Increasing localized blood flow to tissues; liposomes, collagen emulsions; antiulcer agents; promoting hair growth; treating erectile dysfunction |